Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M826Revenue $M47.1Net Margin (%)-6.2Z-Score3.1
Enterprise Value $M447EPS $-2.6Operating Margin %-1.2F-Score5
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)-6.2Higher ROA y-yY
Price/Book3.310-y EBITDA Growth Rate %0Quick Ratio6.7Cash flow > EarningsY
Price/Sales5.25-y EBITDA Growth Rate %17.7Current Ratio6.7Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-4.0Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-5.1Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M48.8ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with INFI

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
INFIJohn Burbank 2014-06-30 Sold Out -0.01%$8.6 - $12.67
($10.38)
$ 16.9463%Sold Out0
INFIJohn Burbank 2014-03-31 Buy 0.01%$11.37 - $16.52
($13.45)
$ 16.9426%New holding, 16556 sh.16,556
INFIGeorge Soros 2013-06-30 Sold Out -0.02%$16.192 - $50.09
($30.95)
$ 16.94-45%Sold Out0
INFIGeorge Soros 2013-03-31 Reduce-0.01%$32.93 - $49.37
($39.51)
$ 16.94-57%Reduce -46.67%40,000
INFIGeorge Soros 2012-12-31 Buy 0.03%$17.74 - $35.04
($25.26)
$ 16.94-33%New holding, 75000 sh.75,000
INFIJean-Marie Eveillard 2012-06-30 Sold Out -0.01%$11.71 - $13.76
($12.78)
$ 16.9433%Sold Out0
INFIJean-Marie Eveillard 2012-03-31 Reduce-0.01%$5.9781 - $12.16
($7.96)
$ 16.94113%Reduce -54.94%180,000
INFIJean-Marie Eveillard 2011-09-30 Reduce-0.01%$6.17 - $10.36
($7.87)
$ 16.94115%Reduce -25.85%464,241
INFIWilbur Ross 2011-06-30 Sold Out $5.61 - $8.19
($6.53)
$ 16.94159%Sold Out0
INFIJean-Marie Eveillard 2010-12-31 Add0.01%$5.12 - $6.86
($6.13)
$ 16.94176%Add 60.34%585,437
INFIWilbur Ross 2010-12-31 Reduce-0.02%$5.12 - $6.86
($6.13)
$ 16.94176%Reduce -63.91%7,415
INFIJean-Marie Eveillard 2010-09-30 Add$4.62 - $6.3
($5.51)
$ 16.94207%Add 29.72%365,123
INFIWilbur Ross 2010-09-30 Reduce-0.01%$4.62 - $6.3
($5.51)
$ 16.94207%Reduce -25.39%20,545
INFIJean-Marie Eveillard 2010-06-30 Add0.01%$5.88 - $7.94
($6.59)
$ 16.94157%Add 566.95%281,460
INFIJean-Marie Eveillard 2009-12-31 Add$5.5 - $6.57
($5.92)
$ 16.94186%Add 451.43%42,201
INFIJean-Marie Eveillard 2009-09-30 Buy $5.42 - $8.8
($6.97)
$ 16.94143%New holding, 7653 sh.7,653
INFIWilbur Ross 2009-03-31 Buy 0.12%$7.1 - $8.28
($7.9)
$ 16.94114%New holding, 28437 sh.28,437
INFIJean-Marie Eveillard 2008-12-31 Buy $4.73 - $8.05
($6.3)
$ 16.94169%New holding, 28100 sh.28,100
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

INFI is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


INFI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Palombella Vito J.Chief Scientific Officer 2014-12-15Sell4,737$16.323.8view
Palombella Vito J.Chief Scientific Officer 2014-11-26Sell4,736$1512.93view
EVNIN ANTHONY BDirector 2014-09-30Sell112,451$13.5624.93view
Palombella Vito J.Chief Scientific Officer 2014-09-03Sell9,472$15.3910.07view
Palombella Vito J.Chief Scientific Officer 2014-07-01Sell879$12.8731.62view
Palombella Vito J.Chief Scientific Officer 2014-02-25Sell4,736$1512.93view
Palombella Vito J.Chief Scientific Officer 2014-01-02Sell753$13.5225.3view
EVNIN ANTHONY BDirector 2013-12-02Sell17,756$14.5616.35view
EVNIN ANTHONY BDirector 2013-11-27Sell163,864$14.8214.3view
Palombella Vito J.Chief Scientific Officer 2013-09-27Sell4,736$17.28-1.97view

Press Releases about INFI :

    Quarterly/Annual Reports about INFI:

    News about INFI:

    Articles On GuruFocus.com

    More From Other Websites
    Nasdaq stocks posting largest percentage decreases Dec 17 2014
    Lightning Round: I want this to go lower Dec 15 2014
    Response to Terra Firma announcement Dec 15 2014
    Infinity Reports New Results from Phase 1 Study of Investigational Oncology Compound Duvelisib at... Dec 09 2014
    Infinity Reports New Results from Phase 1 Study of Investigational Oncology Compound Duvelisib at... Dec 09 2014
    Infinity Reports New Translational Research and Updated Phase 1 Data of Investigational Oncology... Dec 08 2014
    Infinity Reports New Translational Research and Updated Phase 1 Data of Investigational Oncology... Dec 08 2014
    Infinity Pharmaceuticals (INFI) Is Today's Strong On High Volume Stock Nov 26 2014
    Infinity to Present at the Deutsche Bank Securities 2014 BioFEST Conference Nov 24 2014
    Infinity to Present at the Deutsche Bank Securities 2014 BioFEST Conference Nov 24 2014
    INFINITY PHARMACEUTICALS, INC. Financials Nov 18 2014
    Infinity Pharmaceuticals (INFI) Upgraded From Sell to Hold Nov 14 2014
    INFINITY PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report Nov 10 2014
    Infinity beats 3Q profit forecasts Nov 06 2014
    Infinity beats 3Q profit forecasts Nov 06 2014
    Infinity Pharmaceuticals Inc Earnings Call scheduled for 4:30 pm ET today Nov 06 2014
    INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Nov 06 2014
    Infinity Reports Third Quarter 2014 Financial Results and Provides Company Update Nov 06 2014
    Infinity Announces Clinical and Preclincal Data for Duvelisib to Be Presented at ASH 2014 Annual... Nov 06 2014
    Infinity Announces Clinical and Preclincal Data for Duvelisib to Be Presented at ASH 2014 Annual... Nov 06 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK